Glucagonlike Peptide 1-Based Therapies Associated With Acute Pancreatitis in Study
In a study by Sonal Singh, M.D., M.P.H., of The Johns Hopkins University School of Medicine, Baltimore, and colleagues, treatment with the glucagonlike peptide-1 (GLP-1)-based therapies sitagliptin and exenatide were associated with increased odds... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 26, 2013 Category: Pharmaceuticals Source Type: clinical trials

Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS)
Conditions:   Stem Cell Transplantation;   Ventricular Dysfunction, LeftInterventions:   Genetic: Lower dose mesenchymal stem cell (MSC) injection;   Genetic: Placebo;   Genetic: Higher dose MSC injectionSponsors:   Joshua M Hare;   National Heart, Lung, and Blood Institute (NHLBI);   Johns Hopkins University Specialized Center for Cell Based Therapy;   The EMMES CorporationCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 2, 2008 Category: Research Source Type: clinical trials